Skip to content
Screener

Bio-Rad Laboratories BIO Q1 2025 earnings

Reported May 1, 2025 · After market close

Revenue$585.4MBeat by $12.2M
EPS$2.54Beat by $0.81
Revenue estimate$573.2M
EPS estimate$1.73

Next report

Oct 29, 2026 (in a month)
Revenue estimate$650.6M
EPS estimate$2.23

Financials

Q1 2025

Income statement

See full
Revenue$585.4M-4.2%
Gross profit$306.0M-6.1%
Operating income$23.7M-46.9%
Net income$64.0M-83.3%
EPS (diluted)$2.29-83.0%

Balance sheet

See full
Cash & equivalents$523.1M+20.6%
Total debt$1.4B-2.2%
Total equity$6.7B-26.2%
Total assets$9.5B-24.4%

Cash flow

See full
Operating cash flow$129.9M+86.1%
CapEx$34.4M-14.4%
Free cash flow$95.5M+223%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$6.82B-30.8%
Enterprise value$7.68B-29.2%
P/S2.7×-1.1×

Profitability

See full
Gross margin53.5%+0.1pp
Operating margin9.8%-2.5pp
Net margin-85.2%-103pp
FCF margin14%+6.9pp

Returns & leverage

See full
Return on equity-27.5%-32.1pp
Debt / equity0.2×+0.1×
Current ratio6×-0.6×

Segments

By segment

See full
Clinical Diagnostics$356.8M-3.2%
Life Science$228.6M-5.4%
All Other Segments--100%

By geography

See full
Europe$199.8M-0.2%
Asia Pacific$104.1M-11.2%
Americas$39.8M-1.7%

FAQ

When did Bio-Rad Laboratories report Q1 2025 earnings?
Bio-Rad Laboratories (BIO) reported Q1 2025 earnings on May 1, 2025 after market close.
What were Bio-Rad Laboratories's Q1 2025 revenue and EPS?
Bio-Rad Laboratories reported revenue of $585.4M and eps of $2.54 for Q1 2025.
Did Bio-Rad Laboratories beat estimates in Q1 2025?
Revenue beat the consensus estimate of $573.2M by $12.2M. EPS beat the consensus estimate of $1.73 by $0.81.
How did Bio-Rad Laboratories's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 4.2% from $610.8M a year earlier and eps grew 10.9% from $2.29.
Where can I find Bio-Rad Laboratories's Q1 2025 SEC filings?
You can read the 8-K earnings release (0000012208-25-000025) and the 10-Q periodic report (0000012208-25-000026) directly on SEC EDGAR. The filing index links above go to sec.gov.